Utility of Biomarkers in Prediction of Future Cognition in Alzheimer's Disease Continuum Changes Over time
Mohammad Hossein Dehghani, Elham Ramezannezhad
0 citationsZenodo (CERN European Organization for Nuclear Research)
Elham Ramezannezhad
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
22Publications signalées
171Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsMultiple Sclerosis Research StudiesAdvanced Neuroimaging Techniques and ApplicationsNeurological disorders and treatments
Publications récentes
Utility of Biomarkers in Prediction of Future Cognition in Alzheimer's Disease Continuum Changes Over time
Mohammad Hossein Dehghani, Elham Ramezannezhad
0 citationsZenodo (CERN European Organization for Nuclear Research)
Serum Lipoprotein Subclasses as Predictors of Tensor-Based Morphometry Atrophy in the Alzheimer Disease Continuum
Farbod Khosravi, Mitra Ashrafi, Donya Abroushan, Elham Ramezannezhad et autres
0 citationsAlzheimer Disease & Associated Disorders
Correction: Evaluating the Predictive Value of Oxylipins for Cognitive Measures and White Matter Hyperintensities in Alzheimer’s Disease Continuum Compared to Conventional Beta‑amyloid and Tau Protein Biomarkers
Alireza Haghighi, Mahsa Mayeli, Elham Ramezannezhad, Negin Pouroushaninia et autres
0 citationsMolecular Neurobiology
Comparing the predictive value of plasma p-tau217 and CSF biomarkers (p-tau181, Aβ42) using amyloid positron emission tomography in Alzheimer's continuum
Mohammad Hossein Azaraein, Elham Zarrazvand, Fatemeh Heydari, Nasim Asimi et autres
0 citationsResearch Square
Tensor-based morphometry findings corresponding to the novel serum p-tau 217 biomarkers levels in the Alzheimer’s dementia continuum
Amirhossein Ghasemiazar, Maryam Sadat Alyasin, Elham Ramezannezhad, Zahra Khodadadi et autres
0 citationsResearch Square
Evaluating the Predictive Value of Oxylipins for Cognitive Measures and White Matter Hyperintensities in Alzheimer’s Disease Continuum Compared to Conventional Beta‑amyloid and Tau Protein Biomarkers
Alireza Haghighi, Mahsa Mayeli, Elham Ramezannezhad, Negin Pouroushaninia et autres
0 citationsMolecular Neurobiology
Investigating the interaction of hsa-miR-193b-5p and hsa-circ-cnot11-0001 in multiple sclerosis disease through dual luciferase assay
Amirreza Pashapouryeganeh, Elham Mohammed Khatrawi, Zohreh Pajohesh, Rosa Hosseinzadegan et autres
1 citationGene Reports
Associations Between Metabolomics Findings and Brain Hypometabolism in Mild Cognitive Impairment and Alzheimer’s Disease
Moein Mir, Parinaz Khosravani, Elham Ramezannezhad, Fatemeh Pourali Saadabad et autres
2 citationsCurrent Alzheimer Research
Longitudinal impact of cholinesterase inhibitors on cholinergic white matter integrity in mild cognitive impairment: A diffusion MRI study
0 citationsJournal of Alzheimer s Disease Reports
High-Density Lipoprotein (HDL) Subtypes Adversely Alter Brain Structure in Mild Cognitive Impairment: A Tensor-Based Morphometry Analysis
Ali Azargoonjahromi, Mitra Ashrafi, Donya Abroushan, Elham Ramezannezhad et autres
1 citationmedRxiv
T1 and T2 weighted lesions and cognition in multiple Sclerosis: A systematic review and meta-analysis
Fardin Nabizadeh, Kasra Pirahesh, Mobin Azami, Asra Moradkhani et autres
3 citationsJournal of Clinical Neuroscience
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.